What is the value of growth hormone treatment in short children with specified syndrome? Turner's syndrome, osteochondrodysplasias, Prader-Willi syndrome, Noonan syndrome.
Nilsson
K O
KO
Department of Pediatrics, University of Lund, Malmö General Hospital, Sweden.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy*; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009634:Noonan Syndrome / Q000188:drug therapy*; D010009:Osteochondrodysplasias / Q000188:drug therapy*; D010074:Oxandrolone / Q000627:therapeutic use; D011218:Prader-Willi Syndrome / Q000188:drug therapy*; D014424:Turner Syndrome / Q000188:drug therapy*
D004967:Estrogens; D010074:Oxandrolone; D013006:Growth Hormone